指南与共识类风湿关节炎脊柱关节炎系统性红斑狼疮

饮食对风湿与肌肉骨骼疾病结局的影响:为2021年EULAR风湿与肌肉骨骼疾病患者生活方式改善建议提供依据的系统综述与荟萃分析

Effects of diet on the outcomes of rheumatic and musculoskeletal diseases (RMDs): systematic review and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs.
指南 / 共识 · RMD Open · 2022-01-01

EULAR工作组为制定风湿与肌肉骨骼疾病(RMDs)生活方式建议,系统综述并荟萃分析了饮食与七种RMDs疾病进展关系的研究,共纳入24篇系统综述和150篇原始研究。多数饮食暴露研究较少,仅维生素D、软骨素、氨基葡萄糖(OA)和omega-3(RA)等有中等证据显示对疾病进展有小效应。目前缺乏个体饮食暴露对RMDs结局具有临床意义效应量的高级别证据。

要点

  • 共纳入24篇系统综述和150篇原始研究,评估了83种饮食暴露。
  • 多数饮食暴露研究较少,OA和RA人群研究最多。
  • 维生素D、软骨素、氨基葡萄糖(OA)和omega-3(RA)有中等证据显示小效应。

核心结论

  • 当前文献提示某些饮食成分有小益处的证据等级为中等。
  • 缺乏个体饮食暴露对RMDs结局具有临床意义效应量的高级别证据。

研究设计与样本

  • EULAR工作组为制定RMDs患者生活方式建议,对饮食与七种RMDs疾病结局的研究进行系统综述和荟萃分析。
  • 七种RMDs包括骨关节炎(OA)、类风湿关节炎(RA)、系统性红斑狼疮、中轴型脊柱关节炎、银屑病关节炎、系统性硬化症和痛风。
  • 第一阶段识别2013至2018年发表的现有相关系统综述和荟萃分析。
  • 第二阶段扩展纳入已发表的饮食与RMDs原始研究,无发表时间限制。
  • 纳入标准为评估上述RMDs中一种疾病的饮食暴露并报告疾病进展(如疼痛、功能、关节损伤)结果的研究。

主要发现

  • 共研究83种饮食暴露,但大多数研究针对OA和RA人群。
  • 多数饮食暴露仅由相对较少的研究评估。
  • 经多项设计良好研究评估的暴露(如OA:维生素D、软骨素、氨基葡萄糖;RA:omega-3)被归类为对疾病进展有小效应的中等证据。

关键数值与推荐

  • OA的维生素D、软骨素、氨基葡萄糖及RA的omega-3被归类为对疾病进展有小效应的中等证据。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 多数饮食暴露仅由相对较少的研究评估。
  • 缺乏个体饮食暴露对RMDs结局具有临床意义效应量的高级别证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A EULAR taskforce was convened to develop recommendations for lifestyle behaviours in rheumatic and musculoskeletal diseases (RMDs). In this paper, the literature on the effect of diet on the progression of RMDs is reviewed. METHODS: Systematic reviews and meta-analyses were performed of studies related to diet and disease outcomes in seven RMDs: osteoarthritis (OA), rheumatoid arthritis (RA), systemic lupus erythematosus, axial spondyloarthritis, psoriatic arthritis, systemic sclerosis and gout. In the first phase, existing relevant systematic reviews and meta-analyses, published from 2013 to 2018, were identified. In the second phase, the review was expanded to include published original studies on diet in RMDs, with no restriction on publication date. Systematic reviews or original studies were included if they assessed a dietary exposure in one of the above RMDs, and reported results regarding progression of disease (eg, pain, function, joint damage). RESULTS: In total, 24 systematic reviews and 150 original articles were included. Many dietary exposures have been studied (n=83), although the majority of studies addressed people with OA and RA. Most dietary exposures were assessed by relatively few studies. Exposures that have been assessed by multiple, well conducted studies (eg, OA: vitamin D, chondroitin, glucosamine; RA: omega-3) were classified as moderate evidence of small effects on disease progression. CONCLUSION: The current literature suggests that there is moderate evidence for a small benefit for certain dietary components. High-level evidence of clinically meaningful effect sizes from individual dietary exposures on outcomes in RMDs is missing.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Gwinnutt JM, Wieczorek M, Rodríguez-Carrio J, et al. Effects of diet on the outcomes of rheumatic and musculoskeletal diseases (RMDs): systematic review and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs. RMD Open. 2022. PMID: 35654458. doi:10.1136/rmdopen-2021-002167

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。